sexta-feira, 20 de março de 2020

HYDROXYCHLOROQUINE FOR TREATMENT OF INFECTION CAUSED BY COVID-19

FDA has accepted for clinical trial (Hydroxy)chloroquine (CHQ) Sulfate as potential drug to treat COVID-19 infection! No other option now! At this point off-label use, no problems.


Would HYDROXYCHLOROQUINE plus CONVALESCENT PLASMA plus ZITHROMAX plus (IV) ASCORBIC ACID be the optimal treatment for SARS-Cov-2??

Let us see the upcoming reports from the West to compare with the Asian ones. Success rate in China 87.87% up to now. There are 6,569 active cases in China, so success rate might shift a little bit but not much.

Chloroquine was the ELECTED drug by China´s Government since February to treat COVID-19 infected patients. 

"The drug is recommended for inclusion in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia caused by COVID-19 issued by the National Health Commission of the People's Republic of China." Accordingly with https://www.ncbi.nlm.nih.gov/pubmed/32074550

Nenhum comentário:

Postar um comentário

Observação: somente um membro deste blog pode postar um comentário.

Marcadores